Our mission
BenzoHelp advances informed prescribing, patient-centered deprescribing, continuity of care, and public understanding of benzodiazepine physical dependence and withdrawal.
What we believe
- Patients deserve understandable information about benefits, risks, physical dependence, interactions, and discontinuation.
- Physical dependence must not automatically be treated as addiction.
- Medication decisions should be individualized and made with qualified healthcare professionals.
- Listening to lived experience and using sound clinical evidence are complementary.
- Stopping medication should not end appropriate care for the condition being treated.
What BenzoHelp does not do
We do not diagnose, prescribe, direct individual medication changes, certify clinicians, or provide emergency services. We do not accept pharmaceutical-company control over editorial content.
Editorial and medical-review standard
Source hierarchy
We prioritize government safety communications, multidisciplinary clinical guidelines, systematic reviews, and peer-reviewed research. We label lived experience and opinion as such.
Review
Clinical material should be reviewed by appropriately qualified independent professionals before publication. Each substantive page displays a review date and is rechecked when major guidance changes.
Conflicts and funding
Authors, advisers, reviewers, funders, and relevant conflicts should be publicly disclosed. Financial support should not buy editorial influence.
Privacy and stories
Personal stories require informed, revocable consent before publication. Contributors should understand where and how their words may appear. Identifying details should be minimized.
Governance under development
BenzoHelp’s goal is to establish an independent board, a clinical advisory group, and a lived-experience council. Names, roles, decision-making responsibilities, and conflicts should be published here when appointments are made.
Corrections policy
We welcome specific corrections. Please identify the page, the statement at issue, and a supporting source. Material errors should be corrected promptly and significant changes summarized publicly.
Email: [email protected]
Contact
General inquiries and partnerships: [email protected]
Media and speaking: [email protected]